retatrutide weight loss phase 2 trial nejm 48 weeks Eli Lilly's shows promising results in 3 Phase 2 Trial of Retatrutide – retatrutide phase 2 trial duration

Moore, who became the highest paid actress in history in the mid-90s, revealed in her 2019 memoir "Inside Out" that she battled an eating disorder at the height of her fame

A total of 1,456 HE were documented within the dataset, of which 1,355 (93.06%) were associated with ADEs, affecting 1,264 patients

Key points Human IGF-1 and LR3 IGF-1 are produced in the P

PMCID: PMC7902646

The phase 2 trial published in The New England Journal of Medicine in 2023 enrolled adults with obesity without type 2 diabetes and demonstrated dose-dependent weight loss of up to 24.2% of body weight at the highest dose over 48 weeks results that attracted considerable scientific and media attention